Back to Search Start Over

60 Degrees announces first patient enrolled in clinical trial of Tafenoquine

Source :
The Fly. June 27, 2024
Publication Year :
2024

Abstract

60 Degrees Pharmaceuticals announced that the first patient has been enrolled in a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of tafenoquine in treating babesiosis in [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
The Fly
Publication Type :
Periodical
Accession number :
edsgcl.799181461